Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Could coenzyme Q10 and L-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA?

× No keyword cloud information.

15 in total

1. Heterogeneity of metabolic response to muscular exercise in humans. New criteria of invariance defined by in vivo phosphorus-31 NMR spectroscopy.

Authors: D Bendahan; S Confort-Gouny; G Kozak-Reiss; P J Cozzone
Journal: FEBS Lett Date: 1990-10-15 Impact factor: 4.124

2. Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone.

Authors: Y Ihara; R Namba; S Kuroda; T Sato; T Shirabe
Journal: J Neurol Sci Date: 1989-05 Impact factor: 3.181

3. Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study.

Authors: Y Nishikawa; M Takahashi; S Yorifuji; Y Nakamura; S Ueno; S Tarui; T Kozuka; T Nishimura
Journal: Neurology Date: 1989-03 Impact factor: 9.910

4. Adult-onset diabetes mellitus and neurosensory hearing loss in maternal relatives of MELAS patients in a family with the tRNA(Leu(UUR)) mutation.

Authors: A M Remes; K Majamaa; R Herva; I E Hassinen
Journal: Neurology Date: 1993-05 Impact factor: 9.910

5. Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics.

Authors: Y Oka; H Katagiri; Y Yazaki; T Murase; T Kobayashi
Journal: Lancet Date: 1993-08-28 Impact factor: 79.321

6. Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene.

Authors: M Kishimoto; M Hashiramoto; S Araki; Y Ishida; T Kazumi; E Kanda; M Kasuga
Journal: Diabetologia Date: 1995-02 Impact factor: 10.122

7. Mitochondrial diabetes mellitus: prevalence and clinical characterization of diabetes due to mitochondrial tRNA(Leu(UUR)) gene mutation in Japanese patients.

Authors: H Katagiri; T Asano; H Ishihara; K Inukai; M Anai; T Yamanouchi; K Tsukuda; M Kikuchi; H Kitaoka; N Ohsawa
Journal: Diabetologia Date: 1994-05 Impact factor: 10.122

Could coenzyme Q10 and L-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA?

1. Heterogeneity of metabolic response to muscular exercise in humans. New criteria of invariance defined by in vivo phosphorus-31 NMR spectroscopy.

2. Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone.

3. Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study.

4. Adult-onset diabetes mellitus and neurosensory hearing loss in maternal relatives of MELAS patients in a family with the tRNA(Leu(UUR)) mutation.

5. Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics.

6. Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene.

7. Mitochondrial diabetes mellitus: prevalence and clinical characterization of diabetes due to mitochondrial tRNA(Leu(UUR)) gene mutation in Japanese patients.

8. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA.

9. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial.

10. Multicenter trial with ubidecarenone: treatment of 44 patients with mitochondrial myopathies.

1. Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry.